Why the study?
Postoperative nausea and vomiting is a major complication after abdominal surgery, and gabapentin has recently been used for its prevention.
Does prophylactic gabapentin prevent postoperative nausea and vomiting in laparoscopic cholecystectomy patients?
Does prophylactic gabapentin prevent postoperative nausea and vomiting in laparoscopic cholecystectomy patients?
Prophylactic gabapentin significantly reduces postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
Supports prophylactic gabapentin for PONV prevention after laparoscopic cholecystectomy; confirms efficacy versus placebo in this RCT.
Background: Postoperative nausea and vomiting (PONV) is a major complication after abdominal surgery. Gabapentine has versatile role in case of convulsion and neuropathic pain management. Recently it has been used for the prevention of PONV. Objective: To evaluate the action of prophylactic gabapentin in preventing PONV in Laparoscopic cholecystectomy patients. Methods: It was a randomized placebo-controlled, double-blind study conducted in the Department of Anesthesiology, Dhaka Medical College Hospital from August 2016 to January 2017. A total number of 220 patients were selected by purposive sampling. They were divided into 2 Each group 110. After obtaining a detailed history, General physical and systemic examinations were done for all enrolled patients, after obtaining a detailed history and relevant investigations were done. The results were tested by chi-square test to see their level of significance level at <0.05. Results: Of the 220 patients, 51.81% male and 48.18% were female patients respectively belonged to the study group whereas 55.45% and 44.54% were male and female patients. The mean age of the study group and control group were 45.31±13.63 and 47.03±15.51. The mean BMI in both groups was 23.69±3.12 and 24.17±4.73. The mean arterial pressure in both groups was 96.73±8.19 and 93.35±6.37. The total mean of intravenous fluid study and control group were 1233.7±29.5 and 1139.83±55.69. The total duration of surgery in the study group was 51.77±3.95 and the control group was 46.63±7.89. From the point of view of PONV, gabapentine has shown significantly higher efficacy than placebo (P=<0.05). Out of 53 patients affected by PONV in the study group 13(24.52%), 30(56.60%), and 10(18.86%) patients were categorized as mild-moderate and severe PONV whereas 29(26.36%) 71(64.54%) and 20(18.18%) were upholder as their counterpart in the control group. In severe grade, there was no statistically significant difference found between the groups but in mild...........
No takes yet. Share an insight, caveat, or question.
Tusher et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: